961.11 Authority to control. (1) The controlled substances board shall administer this subchapter and may add substances to or delete or reschedule all substances listed in the schedules in ss. 961.14, 961.16, 961.18, 961.20 and 961.22 pursuant to the rule-making procedures of ch. 227. (1m) In making a determination regarding a substance, the board shall […]
961.115 Native American Church exemption. This chapter does not apply to the nondrug use of peyote and mescaline in the bona fide religious ceremonies of the Native American Church. History: 1971 c. 219; 1995 a. 448 s. 153; Stats. 1995 s. 961.115. Because the exemption is based upon the unique cultural heritage of Native Americans, […]
961.12 Nomenclature. The controlled substances listed in or added to the schedules in ss. 961.14, 961.16, 961.18, 961.20 and 961.22 may be listed or added by any official, common, usual, chemical or trade name used for the substance. History: 1971 c. 219; 1995 a. 448 s. 154; Stats. 1995 s. 961.12.
961.13 Schedule I tests. (1m) The controlled substances board shall add a substance to schedule I upon finding that the substance: (a) Has high potential for abuse; (b) Has no currently accepted medical use in treatment in the United States; and (c) Lacks accepted safety for use in treatment under medical supervision. (2m) The controlled […]
961.14 Schedule I. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I: (2) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, […]
961.15 Schedule II tests. (1m) The controlled substances board shall add a substance to schedule II upon finding that: (a) The substance has high potential for abuse; (b) The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and (c) The abuse of the […]
961.16 Schedule II. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule II: (2) Substances of plant origin. Any material, compound, mixture or preparation which contains any quantity of any of the following substances in any form, including a […]
961.17 Schedule III tests. (1m) The controlled substances board shall add a substance to schedule III upon finding that: (a) The substance has a potential for abuse less than the substances included in schedules I and II; (b) The substance has currently accepted medical use in treatment in the United States; and (c) Abuse of […]
961.18 Schedule III. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule III: (2m) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous […]
961.19 Schedule IV tests. (1m) The controlled substances board shall add a substance to schedule IV upon finding that: (a) The substance has a low potential for abuse relative to substances included in schedule III; (b) The substance has currently accepted medical use in treatment in the United States; and (c) Abuse of the substance […]
961.20 Schedule IV. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule IV: (2) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous […]
961.21 Schedule V tests. (1m) The controlled substances board shall add a substance to schedule V upon finding that: (a) The substance has low potential for abuse relative to the controlled substances included in schedule IV; (b) The substance has currently accepted medical use in treatment in the United States; and (c) The substance has […]
961.22 Schedule V. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule V: (2) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture or preparation containing any of the following narcotic drugs or their salts, isomers or salts […]
961.23 Dispensing of schedule V substances. The dispensing of schedule V substances is subject to the following conditions: (1) They may be dispensed and sold only in good faith as a medicine and not for the purpose of evading this chapter. (2) They may be sold at retail only by a pharmacist or, if the […]
961.235 Records relating to sales of pseudoephedrine products. (1) In this section: (a) “Records of pseudoephedrine sales” means records required under s. 961.23 (4) (b) with respect to the sale of a pseudoephedrine product. (b) “Stop sale alert” means a real-time notification to a seller of pseudoephedrine products that completion of the sale would result […]
961.24 Publishing of updated schedules. The controlled substances board shall publish updated schedules annually. The failure of the controlled substances board to publish an updated schedule under this section is not a defense in any administrative or judicial proceeding under this chapter. History: 1971 c. 219; 1993 a. 213; 1995 a. 448 s. 229; Stats. […]
961.25 Controlled substance analog treated as a schedule I substance. A controlled substance analog, to the extent it is intended for human consumption, shall be treated, for the purposes of this chapter, as a substance included in schedule I, unless a different treatment is specifically provided. No later than 60 days after the commencement of […]
